The fee for a Chinese pharmaceutical corporation to register "me- too" drugs in China cost RMB1000 ( Approx USD 242). However the same requirement does not apply to american corporations - a fee of RMB 45300 ( Approx USD 7300) is required to register "me-too" drugs in the Chinese market.
The Chinese FDA is discriminating the US pharmaceutical corporations.
The difference of prices is also directly affecting American's ability of exporting "me-too" drugs to Chinese market. The "me-too" drugs market is immensely profitable in China and American corporations are facing heavy and strict regulations by the Chinese FDA. Such policy is affecting the US to create more job opportunities.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
